APA (7th ed.) Citation

KM, A., JE, N., EB, D., JS, L., JA, F., M, S., . . . AE, B. (2022). Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Frontiers in immunology, 13, 880961. https://doi.org/10.3389/fimmu.2022.880961

Chicago Style (17th ed.) Citation

KM, Aloul, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, and Barron AE. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology 13 (2022): 880961. https://doi.org/10.3389/fimmu.2022.880961.

MLA (9th ed.) Citation

KM, Aloul, et al. "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis." Frontiers in Immunology, vol. 13, 2022, p. 880961, https://doi.org/10.3389/fimmu.2022.880961.